Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Ambit Biosciences
3165
Ambit Biosciences
Technology
Biotechnology
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Suggest edits
Founded
2000
Raised
$111M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
Dan
GoFundMe
Industry
Edge
Illumina
Bandsintown
TuSimple
San Diego Comic-Con
Companies in the same industry
Acticor Biotech
RegeneRx
Tricida, Inc.
microDimensions
ONL Therapeutics
Biosortia
HighRes Biosolutions
Kleo Pharmaceuticals
HelixNano
CTI Start-up
Alexa global traffic share
Overview
Funding
3
Add info
Acquired by
29 Sep 2014
Daiichi Sankyo Co., Ltd.
$410,000,000
Latest funding
Show all
$50,000,000
Venture capital - 2012
$30,000,000
Venture capital (Series D) - 2011
Location
San Diego
,
United States
Headquarters
Explore San Diego
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Ambit Biosciences makes some noise.
